vs
PUMA BIOTECHNOLOGY, INC.(PBYI)与ThredUp Inc.(TDUP)财务数据对比。点击上方公司名可切换其他公司
ThredUp Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍($79.7M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 18.5%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $-3.2M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs 11.1%)
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
ThredUp Inc.是一家美国二手时尚在线转售平台企业,主打二手服装、鞋履与配饰的转售交易,创立于2009年,总部位于加利福尼亚州奥克兰,目前已经发展成为全球领先的二手时尚转售交易市场之一。
PBYI vs TDUP — 直观对比
营收规模更大
TDUP
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出9.2%
18.5%
自由现金流更多
PBYI
多$17.6M
$-3.2M
两年增速更快
PBYI
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $75.5M | $79.7M |
| 净利润 | — | $-5.6M |
| 毛利率 | 69.3% | 79.6% |
| 营业利润率 | 22.7% | -8.4% |
| 净利率 | — | -7.0% |
| 营收同比 | 27.7% | 18.5% |
| 净利润同比 | — | 74.3% |
| 每股收益(稀释后) | $0.26 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PBYI
TDUP
| Q4 25 | $75.5M | $79.7M | ||
| Q3 25 | $54.5M | $82.2M | ||
| Q2 25 | $52.4M | $77.7M | ||
| Q1 25 | $46.0M | $71.3M | ||
| Q4 24 | $59.1M | $67.3M | ||
| Q3 24 | $80.5M | $61.5M | ||
| Q2 24 | $47.1M | $66.7M | ||
| Q1 24 | $43.8M | $64.5M |
净利润
PBYI
TDUP
| Q4 25 | — | $-5.6M | ||
| Q3 25 | $8.8M | $-4.2M | ||
| Q2 25 | $5.9M | $-5.2M | ||
| Q1 25 | $3.0M | $-5.2M | ||
| Q4 24 | — | $-21.7M | ||
| Q3 24 | $20.3M | $-24.8M | ||
| Q2 24 | $-4.5M | $-14.0M | ||
| Q1 24 | $-4.8M | $-16.6M |
毛利率
PBYI
TDUP
| Q4 25 | 69.3% | 79.6% | ||
| Q3 25 | 77.7% | 79.4% | ||
| Q2 25 | 76.5% | 79.5% | ||
| Q1 25 | 77.1% | 79.1% | ||
| Q4 24 | 76.4% | 80.4% | ||
| Q3 24 | 63.9% | 79.3% | ||
| Q2 24 | 77.4% | 78.8% | ||
| Q1 24 | 75.5% | 80.1% |
营业利润率
PBYI
TDUP
| Q4 25 | 22.7% | -8.4% | ||
| Q3 25 | 17.6% | -5.3% | ||
| Q2 25 | 12.7% | -6.8% | ||
| Q1 25 | 8.7% | -7.6% | ||
| Q4 24 | 22.6% | -12.1% | ||
| Q3 24 | 27.4% | -17.0% | ||
| Q2 24 | -4.6% | -14.4% | ||
| Q1 24 | -5.3% | -19.2% |
净利率
PBYI
TDUP
| Q4 25 | — | -7.0% | ||
| Q3 25 | 16.2% | -5.2% | ||
| Q2 25 | 11.2% | -6.7% | ||
| Q1 25 | 6.5% | -7.3% | ||
| Q4 24 | — | -32.3% | ||
| Q3 24 | 25.2% | -40.3% | ||
| Q2 24 | -9.6% | -20.9% | ||
| Q1 24 | -11.0% | -25.7% |
每股收益(稀释后)
PBYI
TDUP
| Q4 25 | $0.26 | $-0.06 | ||
| Q3 25 | $0.17 | $-0.03 | ||
| Q2 25 | $0.12 | $-0.04 | ||
| Q1 25 | $0.06 | $-0.04 | ||
| Q4 24 | $0.40 | $-0.19 | ||
| Q3 24 | $0.41 | $-0.22 | ||
| Q2 24 | $-0.09 | $-0.13 | ||
| Q1 24 | $-0.10 | $-0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $38.6M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $59.2M |
| 总资产 | $216.3M | $167.2M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势,按日历期对齐
现金及短期投资
PBYI
TDUP
| Q4 25 | $97.5M | $38.6M | ||
| Q3 25 | $94.4M | $46.2M | ||
| Q2 25 | $96.0M | $41.0M | ||
| Q1 25 | $93.2M | $41.1M | ||
| Q4 24 | $101.0M | $31.9M | ||
| Q3 24 | $96.7M | $43.7M | ||
| Q2 24 | $96.8M | $44.8M | ||
| Q1 24 | $107.2M | $50.1M |
总债务
PBYI
TDUP
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益
PBYI
TDUP
| Q4 25 | $130.3M | $59.2M | ||
| Q3 25 | $115.3M | $59.1M | ||
| Q2 25 | $104.7M | $60.2M | ||
| Q1 25 | $97.1M | $56.1M | ||
| Q4 24 | $92.1M | $56.3M | ||
| Q3 24 | $71.1M | $69.3M | ||
| Q2 24 | $48.5M | $86.5M | ||
| Q1 24 | $51.0M | $93.5M |
总资产
PBYI
TDUP
| Q4 25 | $216.3M | $167.2M | ||
| Q3 25 | $202.9M | $172.5M | ||
| Q2 25 | $194.9M | $173.6M | ||
| Q1 25 | $196.2M | $172.5M | ||
| Q4 24 | $213.3M | $171.2M | ||
| Q3 24 | $220.7M | $214.9M | ||
| Q2 24 | $205.0M | $231.2M | ||
| Q1 24 | $214.1M | $244.3M |
负债/权益比
PBYI
TDUP
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-1.5M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $-3.2M |
| 自由现金流率自由现金流/营收 | 19.1% | -4.0% |
| 资本支出强度资本支出/营收 | 0.0% | 2.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $180.0K |
8季度趋势,按日历期对齐
经营现金流
PBYI
TDUP
| Q4 25 | $14.4M | $-1.5M | ||
| Q3 25 | $9.7M | $6.0M | ||
| Q2 25 | $14.1M | $344.0K | ||
| Q1 25 | $3.6M | $5.7M | ||
| Q4 24 | $15.6M | $663.0K | ||
| Q3 24 | $11.0M | $3.3M | ||
| Q2 24 | $1.0M | $-5.0M | ||
| Q1 24 | $11.2M | $1.4M |
自由现金流
PBYI
TDUP
| Q4 25 | $14.4M | $-3.2M | ||
| Q3 25 | $9.7M | $2.4M | ||
| Q2 25 | $14.1M | $-2.9M | ||
| Q1 25 | $3.6M | $3.9M | ||
| Q4 24 | $15.6M | $-1.8M | ||
| Q3 24 | $11.0M | $1.2M | ||
| Q2 24 | $1.0M | $-5.8M | ||
| Q1 24 | — | $267.0K |
自由现金流率
PBYI
TDUP
| Q4 25 | 19.1% | -4.0% | ||
| Q3 25 | 17.7% | 2.9% | ||
| Q2 25 | 26.8% | -3.8% | ||
| Q1 25 | 7.7% | 5.5% | ||
| Q4 24 | 26.4% | -2.7% | ||
| Q3 24 | 13.7% | 2.0% | ||
| Q2 24 | 2.1% | -8.7% | ||
| Q1 24 | — | 0.4% |
资本支出强度
PBYI
TDUP
| Q4 25 | 0.0% | 2.2% | ||
| Q3 25 | 0.0% | 4.4% | ||
| Q2 25 | 0.0% | 4.2% | ||
| Q1 25 | 0.1% | 2.5% | ||
| Q4 24 | 0.0% | 3.7% | ||
| Q3 24 | 0.0% | 3.5% | ||
| Q2 24 | 0.0% | 1.3% | ||
| Q1 24 | 0.0% | 1.7% |
现金转化率
PBYI
TDUP
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图